Featured Articles
-
Formulation: The Key To Long‑Term Success
1/21/2026
Robust formulations protect long‑term biologic stability, safety, and efficacy by combining scientific insight, early modeling, and process‑aware development to handle variability.
-
From Syringes To Wearables: Formulation's Impact
1/21/2026
High‑concentration biologic formulations for prefilled syringes and on‑body devices enable easier self‑administration, reduce treatment burden, boost adherence, and address complex formulation challenges.
-
A CRDO Path To Faster Biologic Development
1/21/2026
A science‑driven CRDO model accelerates biologic development by combining expert formulation, analytics, and partnerships to reduce risk and improve outcomes.
-
Mass Spectrometry From Discovery To Launch
1/21/2026
Mass spectrometry is now a fast, sensitive tool that supports drug discovery, development, quality control, and lifecycle management through detailed molecular analysis.
-
Driving Biologics Formulation Through Digital, In Silico Transformation
1/21/2026
AI, ML, NLP, and other in‑silico tools are transforming biologics formulation by enabling earlier risk assessment, better formulatability predictions, and faster preclinical workflows.